L. Parrotta

发表

Hit Identification of a Novel Dual Binder for h‐telo/c‐myc G‐Quadruplex by a Combination of Pharmacophore Structure‐Based Virtual Screening and Docking Refinement

Federica Moraca, Roberta Rocca, S. Alcaro, 2016, ChemMedChem.

Rational Design, Synthesis, Biophysical and Antiproliferative Evaluation of Fluorenone Derivatives with DNA G‐Quadruplex Binding Properties

Stefano Alcaro, Anna Artese, Lucia Parrotta, 2010, ChemMedChem.

Conformational studies and solvent-accessible surface area analysis of known selective DNA G-Quadruplex binders.

Stefano Alcaro, Anna Artese, Lucia Parrotta, 2011, Biochimie.

The polymorphisms of DNA G-quadruplex investigated by docking experiments with telomestatin enantiomers.

Stefano Alcaro, Federica Moraca, Anna Artese, 2012, Current pharmaceutical design.

Toward the design of new DNA G-quadruplex ligands through rational analysis of polymorphism and binding data.

Federica Moraca, S. Alcaro, G. Costa, 2013, European journal of medicinal chemistry.

Identification and characterization of new DNA G-quadruplex binders selected by a combination of ligand and structure-based virtual screening approaches.

Stefano Alcaro, Federica Moraca, Anna Artese, 2013, Journal of medicinal chemistry.

Targeting unimolecular G-quadruplex nucleic acids: a new paradigm for the drug discovery?

Stefano Alcaro, Federica Moraca, Anna Artese, 2014, Expert opinion on drug discovery.

Docking Analysis and Resistance Evaluation of Clinically Relevant Mutations Associated with the HIV‐1 Non‐nucleoside Reverse Transcriptase Inhibitors Nevirapine, Efavirenz and Etravirine

V. Calvez, F. Ceccherini‐Silberstein, B. Masquelier, 2011, ChemMedChem.

Incomplete APOBEC 3 G / F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR 5 to CXCR 4 Usage

V. Calvez, F. Ceccherini‐Silberstein, C. Perno, 2015 .

Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 Usage

V. Calvez, F. Ceccherini‐Silberstein, C. Perno, 2015, Antimicrobial Agents and Chemotherapy.

Identification of new G-quadruplex binders by a combined shape- and 2D-fingerprint based virtual screening approach

Federica Moraca, Anna Artese, Simona Distinto, 2011 .

Effect of maraviroc on non-R5 tropic HIV-1: refined analysis of subjects from the phase IIb study A4001029.

F. Ceccherini‐Silberstein, B. Clotet, J. Martinez-Picado, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Macrocyclic naphthalene diimides as G-quadruplex binders.

Stephan A. Ohnmacht, V. Tumiatti, A. Milelli, 2015, Bioorganic & medicinal chemistry.

Identification of New Natural DNA G-Quadruplex Binders Selected by a Structure-Based Virtual Screening Approach

Stefano Alcaro, Anna Artese, Lucia Parrotta, 2013, Molecules.

Molecular and structural aspects of clinically relevant mutations related to the approved non-nucleoside inhibitors of HIV-1 reverse transcriptase.

F. Ceccherini‐Silberstein, C. Perno, S. Alcaro, 2011, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

HCV Genotypes Are Differently Prone to the Development of Resistance to Linear and Macrocyclic Protease Inhibitors

Stefano Alcaro, Anna Artese, Lucia Parrotta, 2012, PloS one.

Conformation and Stability of Intramolecular Telomeric G-Quadruplexes: Sequence Effects in the Loops

M. Palumbo, S. Alcaro, S. Richter, 2013, PloS one.

Molecular Recognition of Human Telomeric DNA by Phenanthroline-Based G-Quadruplex Ligands

S. Alcaro, G. Costa, A. Artese, 2013 .

Structure-Based Virtual Screening of Novel Natural Alkaloid Derivatives as Potential Binders of h-telo and c-myc DNA G-Quadruplex Conformations

Stefano Alcaro, Federica Moraca, Anna Artese, 2014, Molecules.

New raltegravir resistance pathways induce broad cross-resistance to all currently used integrase inhibitors.

V. Calvez, F. Ceccherini‐Silberstein, C. Katlama, 2014, The Journal of antimicrobial chemotherapy.

The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate+emtricitabine-containing HAART both in vivo and in vitro.

F. Ceccherini‐Silberstein, A. Antinori, R. Bellagamba, 2016, Journal of global antimicrobial resistance.

Molecular interaction fields in drug discovery: recent advances and future perspectives

Stefano Alcaro, Anna Artese, Lucia Parrotta, 2013 .

Detecting and understanding genetic and structural features in HIV-1 B subtype V3 underlying HIV-1 co-receptor usage

Chang Liu, Stefano Alcaro, Anna Artese, 2013, Bioinform..

Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir/ritonavir-containing regimen.

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, K. Theys, 2013, The Journal of antimicrobial chemotherapy.

Molecular and structural aspects of clinically relevant mutations related to the approved non-nucleoside inhibitors of HIV-1 reverse transcriptase.

F. Ceccherini‐Silberstein, C. Perno, S. Alcaro, 2011, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.